Treatment of Copper Intra Uterine Device Associated Heavy Menstrual Blood Loss

Assiut University140 enrolled

Overview

Intrauterine contraceptive device is the most commonly reversible method used among women of reproductive age worldwide. Almost one in five married contraceptive users is currently using Intrauterine contraceptive device. The Egyptian demographic and health survey results indicate that 30% of currently married women interviewed in the Egyptian demographic and health survey were using Intrauterine contraceptive device. Main reasons for discontinuation of Intrauterine contraceptive device as cited by women were excessive bleeding per vagina 39.68%, abdominal pain 38.62%, low backache35.97%.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

140

Conditions

Menorrhagia

Interventions

Tranexamic Acid 500 MGDRUG

oral tablets

Calcium DobesilateDRUG

oral tablets

Eligibility

Sex: FEMALEMin age: 20 YearsMax age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Women usingsopperT380A and reporting heavy menstrual blood loss during use. 2. Menorrhagia , will be defined as a Pictorial blood loss assessment chart-Score greater than 100. 3. No contraindication to drugs used in treatment. 4. No other cause for heavy menstrual blood loss Exclusion Criteria: 1. Refusing to participate. 2. Irregular menstrual cycle. 3. Misplaced Intrauterine device.

Locations (1)

Assiut Faculty of Medicine

Asyut, Egypt

RECRUITING

Outcomes

Primary Outcomes

Percent of women requesting treatment for heavy menstrual blood loss.

Time frame: 3 months

Central Contacts

Eriny Morris, MBBCh

CONTACT

00201203211136 ranamorris76@yahoo.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.